Clinical Trial Update: Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating tumor response to ipilimumab in patients with melanoma that has metastasized to the brain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-09